I am a Professor of Medicine in the Division of Gastroenterology and Hepatology and am certified in both gastroenterology and Hepatology and in Transplant Hepatology. My major clinical research focus is on the therapy and diagnosis of hepatocellular carcinoma (HCC). Our group at Northwestern University is very qualified for this particular study as our center is a major referral center for the management of HCC in all stages of disease.

I'm a transplant hepatologist with interests in Wilson disease, transplant outcomes and living donor liver transplantation

Dr Akash Shukla from Mumbai, India has core area of interest is portal hypertension, complications of cirrhosis and vascular liver disorders. He's the first author on the APASL guidelines for management of Budd Chiari syndrome and recently published APASL Guidelines updates on NCPF / IPH. He was also on the steering committee of VALDIG, EASL and part of Baveno 7 panel.

Join AASLD at the 9th Conference on Liver Disease in Africa (COLDA) 2026, where clinicians, researchers, policymakers, and...

Join AASLD and the Latin American Association for the Study of the Liver (ALEH) at the 2026 ALEH Congress in Mexico City. The...

Lisa VanWagner MD MSc FAST FAHA is Associate Professor of Medicine and Director of Clinical Research in the Division of Digestive and Liver Diseases at the University of Texas Southwestern Medical Center in Dallas, Texas. Her clinical research lab utilizes health services research methods to define and characterize cardiometabolic disease risk prediction, prevention, and treatment approaches in patients with chronic liver disease particularly surrounding liver transplantation. She has published over 150 peer-reviewed manuscripts and received continuous NIH funding since 2012. Dr.